Manufacturing: hitting pharma costs where they hurt

A new white paper for looks at the need to save in manufacturing as product development costs continue to rise. The paper, titled Hitting Pharma Costs Where It Hurts’ is published by The Access Group, and aims to explain why manufacturers need more efficient systems support for planning provision of capacity and scheduling efficient operations.

Specifically, it looks at ‘smart systems’ as an alternative to spreadsheets and manual processes.

The Access Group states that drug patent lives are shortening, but the expense of developing new products is on the up. What have traditionally been seen as predictably stable and profitable lines of business are rapidly becoming more costly, the firm says.

This is driving a renewed focus on manufacturing costs. However, maximising the efficiency of plant and skilled labour now requires total visibility of production processes and the ability to create detailed forward plans and day-to-day schedules, which are essential ingredients when striving to maximise profitability.

The message of the white paper is that balancing capacities and capabilities with market requirements, understanding what to make, where and when, is critical to maintaining margins.

To obtain a free copy of the ‘Hitting Pharma costs where it hurts’ white paper from Access, contact: Natalie.Smith@theaccessgroup.com